YU42857B - Process for obtaining antiulceral 2-guanidino-4-(2-subst.amino-4-imidazolyl)-thiazoles - Google Patents
Process for obtaining antiulceral 2-guanidino-4-(2-subst.amino-4-imidazolyl)-thiazolesInfo
- Publication number
- YU42857B YU42857B YU996/83A YU99683A YU42857B YU 42857 B YU42857 B YU 42857B YU 996/83 A YU996/83 A YU 996/83A YU 99683 A YU99683 A YU 99683A YU 42857 B YU42857 B YU 42857B
- Authority
- YU
- Yugoslavia
- Prior art keywords
- thiazoles
- guanidino
- imidazolyl
- amino
- antiulceral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Analysing Materials By The Use Of Radiation (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Lubricants (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/376,486 US4435396A (en) | 1982-05-10 | 1982-05-10 | Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| YU99683A YU99683A (en) | 1986-02-28 |
| YU42857B true YU42857B (en) | 1988-12-31 |
Family
ID=23485203
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU996/83A YU42857B (en) | 1982-05-10 | 1983-05-05 | Process for obtaining antiulceral 2-guanidino-4-(2-subst.amino-4-imidazolyl)-thiazoles |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US4435396A (xx) |
| EP (1) | EP0094191B1 (xx) |
| JP (1) | JPS58206588A (xx) |
| KR (1) | KR860000931B1 (xx) |
| AT (1) | ATE33649T1 (xx) |
| AU (2) | AU539244B2 (xx) |
| CA (1) | CA1201120A (xx) |
| CS (1) | CS252461B2 (xx) |
| DD (1) | DD209828A5 (xx) |
| DE (1) | DE3376322D1 (xx) |
| DK (1) | DK163829B (xx) |
| EG (1) | EG17029A (xx) |
| ES (1) | ES8407045A1 (xx) |
| FI (1) | FI78481C (xx) |
| GR (1) | GR79279B (xx) |
| GT (1) | GT198302123A (xx) |
| HU (2) | HU196377B (xx) |
| IE (1) | IE55229B1 (xx) |
| IL (1) | IL68630A (xx) |
| NO (1) | NO159932C (xx) |
| NZ (1) | NZ204158A (xx) |
| PL (1) | PL141199B1 (xx) |
| PT (1) | PT76662B (xx) |
| SU (1) | SU1195907A3 (xx) |
| YU (1) | YU42857B (xx) |
| ZA (1) | ZA833286B (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4673677A (en) * | 1983-10-03 | 1987-06-16 | Pfizer Inc. | Method for treatment of gastrointestinal disorders |
| US4554276A (en) * | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
| US4560690A (en) * | 1984-04-30 | 1985-12-24 | Pfizer Inc. | 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents |
| US4636498A (en) * | 1984-10-11 | 1987-01-13 | Pfizer Inc. | Formulation of antiinflammatory drugs |
| US4632993A (en) * | 1984-10-11 | 1986-12-30 | Pfizer Inc. | Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide |
| WO1986003203A1 (en) * | 1984-11-22 | 1986-06-05 | Yoshitomi Pharmaceutical Industries, Ltd. | Thienylthiazole derivatives |
| US4814341A (en) * | 1986-08-26 | 1989-03-21 | Reiter Lawrence A | 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents |
| EP0259085B1 (en) * | 1986-08-29 | 1991-08-21 | Pfizer Inc. | 2-guanidino-4-arylthiazoles for treatment of peptic ulcers |
| EP0269239B1 (en) * | 1986-10-29 | 1994-06-08 | Pfizer Inc. | Processes for 2-(1-pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)thiazole and the crystalline dihydrochloride trihydrate thereof |
| CA2165344A1 (en) * | 1993-06-15 | 1994-12-22 | Peter C. Canning | Immune stimulants in bacterial infections |
| PE20110843A1 (es) | 2008-09-22 | 2011-12-08 | Cayman Chem Co | Derivados de 5-(1h-imidazol-5-il)-2-fenilpirimidina, como inhibidores de prostaglandina d sintasa hematopoyetica |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3519637A (en) | 1966-12-06 | 1970-07-07 | Hoffmann La Roche | 1-(4-thiazolylmethyl)nitroimidazole derivatives |
| DE2142585A1 (de) * | 1971-08-20 | 1973-02-22 | Schering Ag | 2-(5-nitro-2-thiazolyl)-benzimidazole |
| FR2284601A1 (fr) * | 1974-09-10 | 1976-04-09 | Inst Francais Du Petrole | Composes guanidino-heterocycliques alkyles, leur preparation et leur utilisation comme additifs pour carburants et lubrifiants |
| US4220654A (en) | 1979-06-04 | 1980-09-02 | Merck & Co., Inc. | Cyclic imidazole cyanoguanidines |
| US4374843A (en) * | 1980-10-14 | 1983-02-22 | Pfizer Inc. | 2-Guanidino-4-heteroarylthiazoles |
-
1982
- 1982-05-10 US US06/376,486 patent/US4435396A/en not_active Expired - Fee Related
-
1983
- 1983-05-03 SU SU833585699A patent/SU1195907A3/ru active
- 1983-05-04 GR GR71297A patent/GR79279B/el unknown
- 1983-05-04 EP EP83302495A patent/EP0094191B1/en not_active Expired
- 1983-05-04 DE DE8383302495T patent/DE3376322D1/de not_active Expired
- 1983-05-04 AT AT83302495T patent/ATE33649T1/de not_active IP Right Cessation
- 1983-05-05 YU YU996/83A patent/YU42857B/xx unknown
- 1983-05-05 CS CS833184A patent/CS252461B2/cs unknown
- 1983-05-06 HU HU862387A patent/HU196377B/hu not_active IP Right Cessation
- 1983-05-06 HU HU831581A patent/HU190899B/hu not_active IP Right Cessation
- 1983-05-06 CA CA000427596A patent/CA1201120A/en not_active Expired
- 1983-05-06 PL PL1983241840A patent/PL141199B1/pl unknown
- 1983-05-06 NZ NZ204158A patent/NZ204158A/en unknown
- 1983-05-06 GT GT198302123A patent/GT198302123A/es unknown
- 1983-05-07 EG EG275/83A patent/EG17029A/xx active
- 1983-05-09 ZA ZA833286A patent/ZA833286B/xx unknown
- 1983-05-09 IL IL68630A patent/IL68630A/xx unknown
- 1983-05-09 ES ES522223A patent/ES8407045A1/es not_active Expired
- 1983-05-09 FI FI831595A patent/FI78481C/fi not_active IP Right Cessation
- 1983-05-09 NO NO831632A patent/NO159932C/no unknown
- 1983-05-09 IE IE1061/83A patent/IE55229B1/en unknown
- 1983-05-09 DD DD83250744A patent/DD209828A5/de not_active IP Right Cessation
- 1983-05-09 AU AU14363/83A patent/AU539244B2/en not_active Ceased
- 1983-05-09 DK DK205883A patent/DK163829B/da not_active Application Discontinuation
- 1983-05-09 KR KR1019830001962A patent/KR860000931B1/ko not_active IP Right Cessation
- 1983-05-09 PT PT76662A patent/PT76662B/pt unknown
- 1983-05-10 JP JP58081601A patent/JPS58206588A/ja active Pending
-
1984
- 1984-07-18 AU AU30815/84A patent/AU566755B2/en not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT73259B (en) | Process for preparing novel substituted pyrazinyl-1,2,4-oxadiazole-5-ones | |
| DE3376322D1 (en) | Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)-thiazoles and process therefor | |
| DE3162298D1 (en) | Process for the preparation of 3-dimethylamino-2,2-dimethyl propanal | |
| HUT36783A (en) | Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane | |
| IE822012L (en) | Insecticide against aphids | |
| YU156481A (en) | Process for obtaining 6-hydrazono-pyrido (2,1-b) quinazoline-11-one | |
| YU39881A (en) | Process for obtaining hypoglycemic guanylamidines | |
| GB2079149B (en) | Method of producing a treatment preparation for improving the fertility of mammals | |
| AU585116B2 (en) | Process for regenerating soybeans | |
| YU55383A (en) | Process for obtaining 1,2,4-triazole-1-yl-propionitrile | |
| ES8402156A1 (es) | Un procedimiento para producir una composicion para un preparado de accion prolongada de nicardipina. | |
| EP0097874A3 (en) | Process for the preparation of 6-exo-alkanoyl-1,3,3-trimethyl-bicyclo(2.2.2.)octan-2-ones | |
| YU92083A (en) | Process for obtaining hypoglycemic 5-substituted oxazolodine 2,4-diones |